Home » Topics » Regulatory

Regulatory
RSS

More effective, better tolerated combinations for migraine

June 9, 2000

Rizatriptan + rofecoxib claimed by Merck for use in migraine

June 9, 2000

New marketing approvals for Gonal-F in both female and male infertility

June 8, 2000

Allegra now available to treat seasonal allergies and chronic hives in children

June 8, 2000

New expanded indication of Enbrel approved by FDA

June 7, 2000

NDA submitted for fast-dissolving Zomig

June 7, 2000

Genentech's single-injection clot buster for heart attack approved by FDA

June 7, 2000

Schering AG's Yasmin approved in The Netherlands

June 5, 2000

3M's QVAR asthma inhaler approved by Health Canada

June 5, 2000

BDNF reported to be useful for liver diseases

June 2, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...
AI drug developer Insilico to raise $292 million in Hong Kong IPO
BioWorld
Insilico Medicine Inc. plans to raise HK$2.27 billion (US$292 million) in its IPO on the Hong Kong Securities Exchange to advance its clinical pipeline and invest...